메뉴 건너뛰기
Expert Opinion on Therapeutic Patents
Volumn 13, Issue 9, 2003, Pages 1465-1468
COX-2 inhibitors
[No Author Info available]
Author keywords

COX 2; Cyclooxygenase; GW 406381; Inflammation; Pain; Rheumatoid arthritis
Indexed keywords

ALKYL GROUP; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; GR 253035; GW 406381; LUMIRACOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; PARECOXIB; PYRIMIDINE DERIVATIVE; ROFECOXIB; TILMACOXIB; UNCLASSIFIED DRUG; VALDECOXIB;
EID: 0141851901     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/eotp.13.9.1465.22943     Document Type: Article
Times cited : (3)
References (7)
  • 1
    • 0025187588 scopus 로고
    • Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice
    • MASFERRER JL, ZWEIFEL BS, SEIBERT K, NEEDLEMAN P: Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J. Clin. Invest. (1990) 86:1375-1379.
    • (1990) J. Clin. Invest. , vol.86 , pp. 1375-1379
    • Masferrer, J.L.1    Zweifel, B.S.2    Seibert, K.3    Needleman, P.4
  • 2
    • 0027146692 scopus 로고
    • Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
    • MITCHELL JA, AKARASEREENONT P, THIEMERMANN C, FLOWER RJ, VANE JR: Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA (1994) 90:11693-11697.
    • (1994) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 11693-11697
    • Mitchell, J.A.1    Akarasereenont, P.2    Thiemermann, C.3    Flower, R.J.4    Vane, J.R.5
  • 3
    • 0003039650 scopus 로고    scopus 로고
    • Specific COX-2 inhibitors - Realizing the promise of safer NSAIDs
    • CARTY TJ, MARFAT A: Specific COX-2 inhibitors - realizing the promise of safer NSAIDs. Curr. Opin. Investig. Drugs (1999) 1(2):89-96.
    • (1999) Curr. Opin. Investig. Drugs , vol.1 , Issue.2 , pp. 89-96
    • Carty, T.J.1    Marfat, A.2
  • 4
    • 0034941659 scopus 로고    scopus 로고
    • Therapeutic potential of COX-2 inhibitors in arthritis
    • JACKSON CG Therapeutic potential of COX-2 inhibitors in arthritis. Expert Opin. Investig. Drugs (2001) 10(7):13171-325.
    • (2001) Expert Opin. Investig. Drugs , vol.10 , Issue.7 , pp. 13171-13325
    • Jackson, C.G.1
  • 5
    • 0030911724 scopus 로고    scopus 로고
    • Selective cyclooxygenase-2 inhibitors: Pharmacology, clinical effects and therapeutic potential
    • RYN JV, PAIRET M: Selective cyclooxygenase-2 inhibitors: pharmacology, clinical effects and therapeutic potential. Expert Opin. Investig. Drugs (1997) 6(5):609-614.
    • (1997) Expert Opin. Investig. Drugs , vol.6 , Issue.5 , pp. 609-614
    • Ryn, J.V.1    Pairet, M.2
  • 6
    • 0034624748 scopus 로고    scopus 로고
    • 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2
    • TALLEY JJ, BROWN DL, CARTER JS et al.: 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J. Med. Chem. (2000) 43(5):775-777.
    • (2000) J. Med. Chem. , vol.43 , Issue.5 , pp. 775-777
    • Talley, J.J.1    Brown, D.L.2    Carter, J.S.3
  • 7
    • 0035145462 scopus 로고    scopus 로고
    • Etoricoxib (MK-0663): Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2
    • RIENDEAU D, PERCIVAL MD, BRIDEAU C et al.: Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J. Pharmacol. Exp. Ther. (2001) 296(2):558-566.
    • (2001) J. Pharmacol. Exp. Ther. , vol.296 , Issue.2 , pp. 558-566
    • Riendeau, D.1    Percival, M.D.2    Brideau, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.